| [1] |
Dube P, DeRiso A, Patel M, et al. Vascular calcification in chronic kidney disease: diversity in the vessel wall [J]. Biomedicines, 2021, 9(4): 404.
|
| [2] |
杨璨粼，张晓良. SNF472：一种新型血管钙化和钙化防御治疗药物[J]. 中华肾脏病杂志，2022, 38(11): 1011-1015.
|
| [3] |
Passos L, Lupieri A, Becker-Greene D, et al. Innate and adaptive immunity in cardiovascular calcification [J]. Atherosclerosis, 2020, 306: 59-67.
|
| [4] |
Li Y, Sun Z, Zhang L, et al. Role of macrophages in the progression and regression of vascular calcification [J]. Front Pharmacol, 2020, 11: 661.
|
| [5] |
Hénaut L, Candellier A, Boudot C, et al. New insights into the roles of monocytes/macrophages in cardiovascular calcification associated with chronic kidney disease [J]. Toxins (Basel), 2019, 11(9): 529.
|
| [6] |
Reinhold S, Blankesteijn WM, Foulquier S. The interplay of WNT and PPARγ signaling in vascular calcification [J]. Cells, 2020, 9(12): 2658.
|
| [7] |
Talwar S, Kant A, Xu T, et al. Mechanosensitive smooth muscle cell phenotypic plasticity emerging from a null state and the balance between Rac and Rho [J]. Cell Rep, 2021, 35(3): 109019.
|
| [8] |
Lee CF, Carley RE, Butler CA, et al. Rac GTPase signaling in immune-mediated mechanisms of atherosclerosis [J]. Cells, 2021, 10(11): 2808.
|
| [9] |
Healy A, Berus JM, Christensen JL, et al. Statins disrupt macrophage Rac1 regulation leading to increased atherosclerotic plaque calcification [J]. Arterioscler Thromb Vasc Biol, 2020, 40(3): 714-732.
|
| [10] |
Jäger E, Murthy S, Schmidt C, et al. Calcium-sensing receptor-mediated NLRP3 inflammasome response to calciprotein particles drives inflammation in rheumatoid arthritis [J]. Nat Commun, 2020, 11(1): 4243.
|
| [11] |
Cobb AM, Yusoff S, Hayward R, et al. Runx2 (Runt-related transcription factor 2) links the DNA damage response to osteogenic reprogramming and apoptosis of vascular smooth muscle cells [J]. Arterioscler Thromb Vasc Biol, 2021, 41(4): 1339-1357.
|
| [12] |
Waring OJ, Skenteris NT, Biessen E, et al. Two-faced Janus: the dual role of macrophages in atherosclerotic calcification [J]. Cardiovasc Res, 2022, 118(13): 2768-2777.
|
| [13] |
于涵，王保兴. 慢性肾脏病血管钙化的分子机制研究进展[J/CD]. 中华肾病研究电子杂志，2021, 10(4): 232-235.
|
| [14] |
Dube PR, Chikkamenahalli LL, Birnbaumer L, et al. Reduced calcification and osteogenic features in advanced atherosclerotic plaques of mice with macrophage-specific loss of TRPC3 [J]. Atherosclerosis, 2018, 270: 199-204.
|
| [15] |
Liu L, Zeng P, Yang X, et al. Inhibition of vascular calcification [J]. Arterioscler Thromb Vasc Biol, 2018, 38(10): 2382-2395.
|
| [16] |
Li P, Wang Y, Liu X, et al. Loss of PARP-1 attenuates diabetic arteriosclerotic calcification via Stat1/Runx2 axis [J]. Cell Death Dis, 2020, 11(1): 22.
|
| [17] |
Yaker L, Tebani A, Lesueur C, et al. Extracellular vesicles from LPS-treated macrophages aggravate smooth muscle cell calcification by propagating inflammation and oxidative stresss [J]. Front Cell Dev Biol, 2022, 10: 823450.
|
| [18] |
Rogers MA, Buffolo F, Schlotter F, et al. Annexin A1-dependent tethering promotes extracellular vesicle aggregation revealed with single-extracellular vesicle analysis [J]. Sci Adv, 2020, 6(38): eabb1244.
|
| [19] |
Kawakami R, Katsuki S, Travers R, et al. S100A9-RAGE axis accelerates formation of macrophage-mediated extracellular vesicle microcalcification in diabetes mellitus [J]. Arterioscler Thromb Vasc Biol, 2020, 40(8): 1838-1853.
|
| [20] |
Jing L, Li L, Sun Z, et al. Role of matrix vesicles in bone-vascular cross-talk [J]. J Cardiovasc Pharmacol, 2019, 74(5): 372-378.
|
| [21] |
Villa-Bellosta R. New insights into endogenous mechanisms of protection against arterial calcification [J]. Atherosclerosis, 2020, 306: 68-74.
|
| [22] |
Schloesser D, Lindenthal L, Sauer J, et al. Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis [J]. J Cell Biol, 2023, 222(2): e202207097.
|
| [23] |
Sha X, Dai Y, Chong L, et al. Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect [J]. J Nanobiotechnology, 2022, 20(1): 506.
|
| [24] |
Simpson CL, Mosier JA, Vyavahare NR. Osteoclast-mediated cell therapy as an attempt to treat elastin specific vascular calcification [J]. Molecules, 2021, 26(12): 3643.
|
| [25] |
Yang D, Wan Y. Molecular determinants for the polarization of macrophage and osteoclast [J]. Semin Immunopathol, 2019, 41(5): 551-563.
|
| [26] |
Ishida K, Ashizawa N, Matsumoto K, et al. Novel bisphosphonate compound FYB-931 preferentially inhibits aortic calcification in vitamin D3-treated rats [J]. J Bone Miner Metab, 2019, 37(5): 796-804.
|
| [27] |
何叶梅，欧三桃. 硫酸吲哚酚与血管钙化的关系的研究进展[J]. 医学研究生学报，2021, 34(11): 1228-1232.
|
| [28] |
Maheshwari V, Tao X, Thijssen S, et al. Removal of protein-bound uremic toxins using binding competitors in hemodialysis: a narrative review [J]. Toxins (Basel), 2021, 13(9): 622.
|